SCHEMBL7720184

SCHEMBL7720184

c1ccc(CO[C@@H]2COC(c3ccccc3)O[C@H]2[C@@H]2OC(c3ccccc3)OC[C@H]2OCc2ccccc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.49
L3MBTL1 Q9Y468 2/20 0.47
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
KLK7 P49862 5/20 0.41
KLK5 Q9Y337 3/20 0.41
SLC6A2 P23975 1/20 0.39
PSEN1 P49768 1/20 0.38
PSEN2 P49810 1/20 0.38
APH1B Q8WW43 1/20 0.38
NCSTN Q92542 1/20 0.38
APH1A Q96BI3 1/20 0.38
PSENEN Q9NZ42 1/20 0.38
CTSV O60911 1/20 0.37
CTSL P07711 1/20 0.37
CTSB P07858 1/20 0.37
CTSS P25774 1/20 0.37
CTSK P43235 1/20 0.37
CTSC P53634 1/20 0.37
CTSF Q9UBX1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18689878 1.00 BCHE (0.49) BCHEL3MBTL1MEN1KMT2AKLK7
SCHEMBL5094203 0.88 KMT2A (0.43) BCHEL3MBTL1MEN1KMT2ATACR1
SCHEMBL20226457 0.88 BCHE (0.44) BCHEL3MBTL1MEN1KMT2AKLK7
SCHEMBL20234108 0.88 BCHE (0.44) BCHEL3MBTL1MEN1KMT2AKLK7
SCHEMBL20226444 0.88 BCHE (0.44) BCHEL3MBTL1MEN1KMT2AKLK7
SCHEMBL20234110 0.88 BCHE (0.44) BCHEL3MBTL1MEN1KMT2AKLK7
SCHEMBL20234109 0.88 BCHE (0.44) BCHEL3MBTL1MEN1KMT2AKLK7
SCHEMBL18688553 0.85 L3MBTL1 (0.40) BCHEL3MBTL1MEN1KMT2AKLK7
SCHEMBL404245 0.84 L3MBTL1 (0.42) BCHEL3MBTL1MEN1KMT2AKLK7
SCHEMBL21964247 0.83 SLC6A2 (0.49) BCHEL3MBTL1MEN1KMT2AKLK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6387395-B1 N-[1, (1-1) -dialkyloxy] - and N- [1, (1-1) -dialkenyloxy]- alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor EPPSTEIN DEBORAH A (US) 2002-05-14 US disclosed
US-5622712-A CONSISTS OF A DRUG AND A QUATERNARY AMMONIUM SALT COMPOUND AS A LIPID COMPONENT SYNTEX (U.S.A.) INC. (US) 1997-04-22 US disclosed
US-5550289-A FOR DNA TRANSFECTION SYNTEX (U.S.A.) INC. (US) 1996-08-27 US disclosed
US-5545412-A USING LIPOPHILIC COMPOUNDS TO TRANSFECT DNA AND FOR DRUG DELIVERY BY FORMING COMPLEXES TO PENETRATE CELLULAR MEMBRANES SYNTEX (U.S.A.) INC. (US) 1996-08-13 US disclosed
US-5366737-A Drug delivery, DNA transfection SYNTEX (U.S.A.) INC. (US) 1994-11-22 US disclosed
US-5208036-A Complexing a liposomal composition with a quaternary ammonium diether SYNTEX (U.S.A.) INC. (US) 1993-05-04 US disclosed
US-5049386-A Drug and DNA delivery SYNTEX (U.S.A.) INC. (US) 1991-09-17 US disclosed
EP-0172007-B1 STABLE LIPOSOMES WITH AQUEOUS-SOLUBLE MEDICAMENTS AND METHODS FOR THEIR PREPARATION SYNTEX (U.S.A.) INC. (US) 1991-05-22 EP disclosed
US-4946787-A DOUBLE COATED LIPOSOME COMPLEX MADE UP OF POLYANION AND A LIPID SYNTEX (U.S.A.) INC. (US) 1990-08-07 US disclosed
EP-0187702-B1 N-(OMEGA,OMEGA-1-DIALKOXY)- AND N-(OMEGA,OMEGA-1-DIALKENOXY)-ALK-1-YL-N,N,N-TRISUBSTITUTED AMMONIUM SURFACTANTS, THEIR PREPARATION AND PHARMACEUTICAL FORMULATIONS CONTAINING THEM SYNTEX (U.S.A.) INC. (US) 1990-03-14 EP disclosed